[Follow-up logbook of patients receiving CAR T-cell therapy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]

Bull Cancer. 2021 Dec;108(12S):S39-S44. doi: 10.1016/j.bulcan.2021.02.012. Epub 2021 May 13.
[Article in French]

Abstract

In the attempt to harmonize practices and to create a national CAR T-cells patient follow-up care logbook, the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) worked on the design of a common national care logbook during the eleventh annual workshops of practice harmonization. The purpose of this logbook was to explain the different phases of the treatment with CAR T-cells and to allow useful monitoring for the patient. This logbook can be also helpful for the different healthcare professionals involved in the patient care. This national logbook will provide important information to the patients undergoing CAR T-cell therapy. In addition to the information booklets already in use, the national logbook simplifies patient follow-up by recording various medical appointments and possible adverse events. This work has been based on tools that had already been put in place by different CAR T-cell centers. This national logbook represents a common "base" and is prepared in the form of index cards to be classified using dividers in a binder. Therefore, the national care logbook will be adaptable for local procedures and guidelines of each center.

Keywords: CAR T-cells; Carnet de suivi; Coordinating nurse; Follow-up care logbook; Harmonisation des pratiques; Infirmier de coordination; Practice harmonization; SFGM-TC.

Publication types

  • Guideline
  • Review

MeSH terms

  • Appointments and Schedules
  • Continuity of Patient Care
  • Health Records, Personal*
  • Humans
  • Immunotherapy, Adoptive / adverse effects
  • Immunotherapy, Adoptive / methods*
  • Pamphlets
  • Patient Care Team
  • Receptors, Chimeric Antigen*
  • Societies, Medical
  • T-Lymphocytes / transplantation

Substances

  • Receptors, Chimeric Antigen